Compound Summary
药名: | (3S)-3-butyl-3H-isobenzofuran-1-one |
别名: | (3S)-3-butyl-3H-2-benzofuran-1-one |
分子式: | C12H14O2 |
成分: | HBIN009611 |
OB_score: | 55.051607 |
CAS_id: | 6066-49-5 |
SymMap_id: | SMIT09595 |
TCMSP_id: | MOL008285 |
植物ID | 拉丁名 | 药用植物名 | 药名 | 来源 | 功能与主治 | 使用民族 |
---|
TCMBANKHE004258 | Radix Angelicae sinensis | 当归根 | To enrich blood, activate blood circulation, regulate menstruation, relieve pain, and relax bowels./Women’s diseases, blood deficiency syndrome, menstrual disorder, amenorrhea and dysmenorrhea, dysmenorrhea due to anemia, thrombophlebitis, neuralgia, arthritis, chronic nephritis, constrictive aortitis, blood vaculty, pernicious anemia, anemia due to folic acid deficiency, dysentery, hepatitis, Raynaud’s disease, lumbago, various pains due to blood stasis and rheumatic impediment, sores, welling abscess, constipation, ulcer in gastrointestinal tract, skin diseases, eczema, dermatitis, neurodermatitis, psoriasis. | |||
TCMBANKHE004523 | Flos Gossampini | 木棉花 | Diarrhea, dysentery, hemoptysis, blood ejection, flooding, incised wound and bleeding, sore toxin, eczema. |
疾病ID | 病名 | 疾病类型 | MeSH | 参考文献 |
---|
靶点ID | 基因名 | 基因别名 | 描述 |
---|
TCMBANKGE000106 | SCN10A | FEPS2; Nav1.8; PN3; SNS; hPN3 | sodium voltage-gated channel alpha subunit 10 |
TCMBANKGE000205 | NOS2 | HEP-NOS; INOS; NOS; NOS2A | nitric oxide synthase 2 |
TCMBANKGE000309 | SCN5A | CDCD2; CMD1E; CMPD2; HB1; HB2; HBBD; HH1; ICCD; IVF; LQT3; Nav1.5; PFHB1; SSS1; VF1 | sodium voltage-gated channel alpha subunit 5 |
TCMBANKGE000425 | DRD1 | DADR; DRD1A | dopamine receptor D1 |
TCMBANKGE000478 | CHEK1 | CHK1 | checkpoint kinase 1 |
TCMBANKGE000633 | ADRB2 | ADRB2R; ADRBR; B2AR; BAR; BETA2AR | adrenoceptor beta 2 |
TCMBANKGE000869 | DRD2 | D2DR; D2R | dopamine receptor D2 |
TCMBANKGE000903 | PTGS1 | COX1; COX3; PCOX1; PES-1; PGG/HS; PGHS-1; PGHS1; PHS1; PTGHS | prostaglandin-endoperoxide synthase 1 |
TCMBANKGE001073 | PTGS2 | COX-2; COX2; GRIPGHS; PGG/HS; PGHS-2; PHS-2; hCox-2 | prostaglandin-endoperoxide synthase 2 |
TCMBANKGE001194 | ADRA2A | ADRA2; ADRA2R; ADRAR; ALPHA2AAR; ZNF32 | adrenoceptor alpha 2A |
TCMBANKGE001467 | LTA4H | - | leukotriene A4 hydrolase |
TCMBANKGE001506 | ADRA1B | ADRA1; ALPHA1BAR | adrenoceptor alpha 1B |
TCMBANKGE001755 | MAOB | - | monoamine oxidase B |
TCMBANKGE001943 | ADRA1D | ADRA1; ADRA1A; ADRA1R; ALPHA1; DAR; dJ779E11.2 | adrenoceptor alpha 1D |
TCMBANKGE003157 | CHRM2 | HM2 | cholinergic receptor muscarinic 2 |
TCMBANKGE003625 | SLC6A4 | 5-HTT; 5-HTTLPR; 5HTT; HTT; OCD1; SERT; SERT1; hSERT | solute carrier family 6 member 4 |
TCMBANKGE005535 | CHRM1 | HM1; M1; M1R | cholinergic receptor muscarinic 1 |
TCMBANKGE006943 | CHRM3 | EGBRS; HM3; PBS | cholinergic receptor muscarinic 3 |
TCMBANKGE007924 | PKIA | PRKACN1 | cAMP-dependent protein kinase inhibitor alpha |
TCMBANKGE008056 | ADRA2C | ADRA2L2; ADRA2RL2; ADRARL2; ALPHA2CAR | adrenoceptor alpha 2C |
TCMBANKGE008124 | ADRA2B | ADRA2L1; ADRA2RL1; ADRARL1; ALPHA2BAR; FAME2; alpha-2BAR | adrenoceptor alpha 2B |
TCMBANKGE008700 | CHRNA2 | - | cholinergic receptor nicotinic alpha 2 subunit |
TCMBANKGE009256 | SLC6A2 | NAT1; NET; NET1; SLC6A5 | solute carrier family 6 member 2 |
TCMBANKGE009758 | PDE3A | CGI-PDE; CGI-PDE A; CGI-PDE-A; HTNB | phosphodiesterase 3A |
TCMBANKGE012155 | SLC6A3 | DAT; DAT1; PKDYS; PKDYS1 | solute carrier family 6 member 3 |
TCMBANKGE014050 | GABRA1 | ECA4; EIEE19; EJM; EJM5 | gamma-aminobutyric acid type A receptor subunit alpha1 |
TCMBANKGE014423 | ADRA1A | ADRA1C; ADRA1L1; ALPHA1AAR | adrenoceptor alpha 1A |
TCMBANKGE014790 | ADRB1 | ADRB1R; B1AR; BETA1AR; FNSS2; RHR | adrenoceptor beta 1 |
TCMBANKGE014941 | DPEP1 | MBD1; MDP; RDP | dipeptidase 1 |